| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.30M | 31.30M | 24.34M | 20.72M | 19.91M | 17.49M |
| Gross Profit | 15.98M | 31.30M | 17.48M | 12.27M | 12.62M | 12.51M |
| EBITDA | 6.96M | 0.00 | 13.35M | -29.12M | 12.52M | 10.72M |
| Net Income | 12.73M | 24.34M | 9.05M | -11.32M | 46.70M | 22.17M |
Balance Sheet | ||||||
| Total Assets | 240.64M | 241.45M | 232.41M | 233.77M | 252.31M | 200.83M |
| Cash, Cash Equivalents and Short-Term Investments | 13.20M | 25.99M | 11.40M | 14.31M | 6.77M | 17.45M |
| Total Debt | 60.19M | 0.00 | 59.85M | 59.74M | 53.94M | 39.81M |
| Total Liabilities | 67.82M | 67.01M | 69.66M | 66.67M | 61.21M | 43.75M |
| Stockholders Equity | 172.82M | 174.44M | 162.75M | 167.10M | 191.10M | 157.08M |
Cash Flow | ||||||
| Free Cash Flow | 7.69M | 8.65M | 11.73M | 9.82M | 12.32M | 10.46M |
| Operating Cash Flow | 7.69M | 8.65M | 11.73M | 9.82M | 12.32M | 10.46M |
| Investing Cash Flow | 3.39M | 21.23M | -430.00K | 6.94M | -24.99M | 23.07M |
| Financing Cash Flow | -13.73M | -15.28M | -14.21M | -9.21M | 1.99M | -25.95M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £58.60M | 4.85 | 10.22% | 8.23% | 8.48% | 207.85% | |
71 Outperform | £157.72M | 9.16 | 7.33% | 7.43% | -10.95% | -30.09% | |
67 Neutral | £234.04M | 5.97 | 9.81% | 6.64% | ― | ― | |
66 Neutral | £37.42M | 54.66 | 4.33% | 7.14% | -41.22% | ― | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
51 Neutral | £50.88M | -11.90 | -0.96% | 5.02% | -9.28% | ― | |
46 Neutral | £50.51M | -9.68 | -2.97% | 3.94% | 16.08% | 56.94% |